B. Metzler seel. Sohn & Co. AG
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1847838
FRANKFURT, 2M
Position in REGN
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$2,512,624
-$26,055 QoQ
Shares Held
3,252
-1.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 20.448954489544896.ToString("F0")%
Shared 0.ToString("F0")%
None 79.55104551045511.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026B. Metzler seel. Sohn & Co. AG holds $257,562,391 across 18 Biotechnology names. REGN ranks #4 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
511,036 | $228,198,014 | |
| 2 | INSM |
INSMED Inc
|
39,243 | $6,417,014 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
8,475 | $2,804,122 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
3,252 | $2,512,624 | |
| 5 | DNLI |
Denali Therapeutics Inc.
|
112,300 | $2,156,160 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
26,338 | $1,651,392 | |
| 7 | TECH |
BIO-TECHNE Corp
|
31,091 | $1,624,815 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
9,241 | $1,561,913 |
All Filings in REGN
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,512,624 | 3,252 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $2,538,679 | 3,289 | Shares | Defined | 2026-01-28 | |
| 2025-09-30 | $1,813,320 | 3,225 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,693,125 | 3,225 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $2,045,391 | 3,225 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $2,393,428 | 3,360 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $3,532,166 | 3,360 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $4,138,956 | 3,938 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $3,685,373 | 3,829 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,170,626 | 3,610 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $4,919,654 | 5,978 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,903,827 | 5,433 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $4,904,546 | 5,969 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $5,824,588 | 8,073 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $5,607,401 | 8,140 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,703,029 | 7,956 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $5,247,229 | 7,513 | Shares | Defined | 2022-05-10 | |
| 2021-12-31 | $4,133,297 | 6,545 | Shares | Defined | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||